Dae Sik Jang Selected Research

Cholinergic Agents (Cholinergics)

1/2020	The effect of maslinic acid on cognitive dysfunction induced by cholinergic blockade in mice.
2/2018	Eclalbasaponin II Ameliorates the Cognitive Impairment Induced by Cholinergic Blockade in Mice.
1/2018	The memory ameliorating effects of DHP1402, an herbal mixture, on cholinergic blockade-induced cognitive dysfunction in mice.
1/2014	Amyrin attenuates scopolamine-induced cognitive impairment in mice.
7/2013	Ethanolic Extract of the Seed of Zizyphus jujuba var. spinosa Ameliorates Cognitive Impairment Induced by Cholinergic Blockade in Mice.
9/2012	The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or Aβ(1-42)-induced cognitive dysfunction in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dae Sik Jang Research Topics

Disease

29	Neoplasms (Cancer) 12/2023 - 10/2002
22	Cognitive Dysfunction 12/2023 - 01/2012
15	Ovarian Neoplasms (Ovarian Cancer) 06/2022 - 09/2015
10	Diabetes Complications 01/2011 - 01/2007
8	Inflammation (Inflammations) 01/2023 - 04/2010
8	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 09/2012
6	Hepatocellular Carcinoma (Hepatoma) 02/2004 - 10/2002
5	Schizophrenia (Dementia Praecox) 03/2022 - 12/2013
5	Septic Shock (Toxic Shock Syndrome) 10/2016 - 12/2013
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2011 - 01/2007
4	Neuralgia (Stump Neuralgia) 06/2023 - 01/2021
4	Hyperalgesia 06/2023 - 01/2021
4	Body Weight (Weight, Body) 09/2022 - 01/2007
4	Obesity 09/2022 - 07/2009
3	COVID-19 01/2024 - 12/2022
3	Neuroinflammatory Diseases 12/2023 - 04/2022
3	Pain (Aches) 11/2022 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2011
3	Sepsis (Septicemia) 10/2016 - 06/2015
3	Endotoxemia 10/2016 - 12/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2016 - 09/2012
3	Cataract (Cataracts) 01/2010 - 08/2007
2	Peripheral Nervous System Diseases (PNS Diseases) 06/2023 - 11/2022
2	Huntington Disease (Huntington's Disease) 01/2023 - 01/2017
2	Infections 12/2022 - 10/2013
2	Hyperglycemia 02/2022 - 05/2007
2	Endometriosis 11/2021 - 01/2019
2	Memory Disorders (Memory Loss) 01/2020 - 05/2017
2	Endometrial Neoplasms (Endometrial Cancer) 04/2017 - 09/2016
2	Albuminuria 01/2011 - 01/2010

Drug/Important Bio-Agent (IBA)

13	Scopolamine (Hyoscine)FDA Link 08/2022 - 01/2012
9	LipopolysaccharidesIBA 12/2023 - 12/2013
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2007
8	NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA 08/2006 - 10/2002
6	Dizocilpine Maleate (Dizocilpine)IBA 03/2022 - 12/2013
6	Cholinergic Agents (Cholinergics)IBA 01/2020 - 09/2012
5	syringaresinolIBA 11/2022 - 08/2003
5	FlavonoidsIBA 11/2021 - 09/2003
5	Advanced Glycation End ProductsIBA 01/2011 - 08/2007
5	ethyl acetateIBA 03/2005 - 10/2002
4	TriterpenesIBA 01/2024 - 01/2014
4	Neurotransmitter Agents (Neurotransmitter)IBA 03/2022 - 07/2013
4	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 08/2007
4	LignansIBA 08/2021 - 04/2017
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 07/2013
4	Messenger RNA (mRNA)IBA 10/2016 - 08/2007
3	Caspase 3 (Caspase-3)IBA 12/2023 - 04/2018
3	Analgesics (Analgesic Drugs)IBA 06/2023 - 01/2021
3	GenisteinIBA 06/2022 - 09/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2020
3	AntioxidantsIBA 01/2022 - 10/2008
3	Annexin A5IBA 09/2021 - 09/2016
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 09/2017
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 01/2016
3	Amyloid (Amyloid Fibrils)IBA 12/2019 - 12/2012
3	Blood Glucose (Blood Sugar)IBA 10/2019 - 01/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 09/2017
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2018 - 01/2014
3	Neuroprotective AgentsIBA 01/2017 - 12/2012
3	Therapeutic UsesIBA 07/2016 - 08/2007
3	spinosinIBA 01/2016 - 05/2014
3	Methanol (Carbinol)IBA 12/2015 - 10/2002
3	AcidsIBA 01/2011 - 01/2010
3	KIOM 79IBA 01/2011 - 05/2007
3	Plant ExtractsIBA 01/2011 - 01/2010
3	isoliquiritigenin (GU 17)IBA 08/2004 - 05/2003
2	SaponinsIBA 01/2024 - 12/2023
2	AcetoneIBA 06/2023 - 09/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 01/2021
2	Conditioned Culture MediaIBA 01/2023 - 01/2018
2	lancemaside AIBA 12/2022 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 09/2021
2	LipidsIBA 09/2022 - 07/2009
2	ApigeninIBA 06/2022 - 06/2010
2	NF-kappa B (NF-kB)IBA 02/2022 - 04/2018
2	Nerve Growth Factors (Neurotrophins)IBA 02/2022 - 01/2019
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 08/2021
2	LuteolinIBA 11/2021 - 06/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2020 - 11/2018
2	Oleanolic AcidIBA 01/2020 - 02/2004
2	maslinic acidIBA 01/2020 - 11/2017
2	Dinoprostone (PGE2)FDA Link 01/2019 - 09/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 09/2017
2	Propidium (Propidium Iodide)IBA 07/2018 - 09/2017
2	CaspasesIBA 07/2018 - 01/2018
2	eclalbasaponin IIIBA 02/2018 - 09/2016
2	Chemokine CCL5IBA 01/2018 - 09/2017
2	Betulinic AcidIBA 11/2017 - 02/2004
2	Cisplatin (Platino)FDA LinkGeneric 06/2017 - 01/2015
2	biflorinIBA 05/2017 - 04/2016
2	echinocystic acidIBA 01/2017 - 09/2016
2	swertisinIBA 01/2017 - 01/2016
2	CytokinesIBA 10/2016 - 12/2013
2	Interleukin-6 (Interleukin 6)IBA 10/2016 - 09/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2016 - 04/2004
2	SugarsIBA 07/2015 - 01/2010
2	sinapinic acidIBA 12/2012 - 08/2003

Therapy/Procedure

5	Traditional Medicine (Folk Remedies) 08/2022 - 09/2015
3	Oral Administration 04/2018 - 08/2007
2	Drug Therapy (Chemotherapy) 06/2023 - 06/2007